Welcome and State of the Movement
View Session
The Patient Pathway: Beginning the Journey with Cognitive Impairment
For many diseases, well-defined diagnostic and care pathways guide patients, doctors, and caregivers through the patient journey. That is not the case for Alzheimer’s. This panel will discuss what that pathway should look like, starting from the moment a patient prepares to discuss their brain health with their doctor, through subsequent referrals to specialists and treatment options, to exploring potential involvement in clinical trials. Key Question: What needs to happen so that people with cognitive impairment have a smooth path to a reliable diagnosis, appropriate treatment, and access to clinical trials?
On the Cutting Edge: Clinician Insights on Utilizing Innovative Medications
Clinicians who treat Alzheimer’s patients have new medications in their arsenal. What insights have they gained in treating people with these drugs? This panel will delve into their experiences, including conversations with patients and care partners, understanding the benefits and risks, managing side effects, and adapting their practices. Hear from physicians on the cutting edge of Alzheimer’s treatments. Key Question: What insights have clinicians gained in treating people with new medications?
Bringing It Home: Successes in Community-Based Public Health
It has been said that health is what happens between doctor’s visits. Where and how we live, work, play, and worship matters for our health. This discussion will explore the latest successes in public health and community interventions in reducing dementia prevalence. How are communities preparing for the aging population and building infrastructure to help all of us live healthier longer? This panel will uncover how collective efforts can make a substantial difference in combating the growing public health crisis that is dementia. Key Question: What is the role of public and community health in reducing our risk of Alzheimer’s and dementia?
.png)
.jpg)
.png)
